EP 1838327 A1 20071003 - LEUKOCYTE HOMOGENATES HAVING A MOLECULAR WEIGHT OF LESS THAN 10.000 DALTON FOR THE TREATMENT OF DEFECTS OF CELLULAR IMMUNITY
Title (en)
LEUKOCYTE HOMOGENATES HAVING A MOLECULAR WEIGHT OF LESS THAN 10.000 DALTON FOR THE TREATMENT OF DEFECTS OF CELLULAR IMMUNITY
Title (de)
LEUKOZYTENHOMOGENISATE MIT EINEM MOLEKULARGEWICHT KLEINER ALS 10.000 DALTON ZUR BEHANDLUNG VON DEFEKTEN DER ZELLULÄREN IMMUNITÄT MIT
Title (fr)
HOMOGENISATS DE LEUCOCYTES AVEC UN POIDS MOLECULAIRE EN DESSOUS DE 10.000 DALTON DANS LE TRAITEMENT DES DEFAUTS DE L'IMMUNITE CELLULAIRE
Publication
Application
Priority
- DE 2005001728 W 20050926
- DE 102004047262 A 20040924
Abstract (en)
[origin: WO2006032268A1] The invention relates to a composition consisting of proteins, peptides and/or peptide constituents, a pharmaceutical product containing said composition, a method for producing said composition, and the use thereof for the prophylaxis or therapy of people and/or patients with pathogenic modifications and/or defects of cellular immunity, especially cancer, sepsis or allergic reactions, in conjunction with cytostatic therapy, chemotherapy and/or radiotherapy.
IPC 8 full level
A61K 35/14 (2006.01); A61K 35/15 (2015.01); A61P 37/04 (2006.01)
CPC (source: EP)
A61K 39/461 (2023.05); A61K 39/4621 (2023.05); A61K 39/46433 (2023.05); A61K 45/06 (2013.01); A61P 1/16 (2018.01); A61P 1/18 (2018.01); A61P 3/04 (2018.01); A61P 3/10 (2018.01); A61P 7/04 (2018.01); A61P 7/06 (2018.01); A61P 9/10 (2018.01); A61P 11/00 (2018.01); A61P 11/02 (2018.01); A61P 11/06 (2018.01); A61P 13/02 (2018.01); A61P 13/08 (2018.01); A61P 15/10 (2018.01); A61P 17/00 (2018.01); A61P 17/02 (2018.01); A61P 17/04 (2018.01); A61P 17/06 (2018.01); A61P 17/10 (2018.01); A61P 17/14 (2018.01); A61P 19/02 (2018.01); A61P 19/10 (2018.01); A61P 21/00 (2018.01); A61P 25/00 (2018.01); A61P 25/02 (2018.01); A61P 25/04 (2018.01); A61P 25/22 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); A61P 25/32 (2018.01); A61P 27/02 (2018.01); A61P 29/00 (2018.01); A61P 29/02 (2018.01); A61P 31/00 (2018.01); A61P 31/04 (2018.01); A61P 31/18 (2018.01); A61P 31/22 (2018.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); A61P 37/00 (2018.01); A61P 37/02 (2018.01); A61P 37/04 (2018.01); A61P 37/06 (2018.01); A61P 37/08 (2018.01); A61K 2239/38 (2023.05)
C-Set (source: EP)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006032268 A1 20060330; AU 2005287726 A1 20060330; BR PI0517348 A 20081007; CA 2580616 A1 20060330; CN 101056645 A 20071017; DE 102004047262 A1 20060406; EP 1838327 A1 20071003; JP 2008514555 A 20080508; MX 2007003488 A 20070518; RU 2007115380 A 20081027
DOCDB simple family (application)
DE 2005001728 W 20050926; AU 2005287726 A 20050926; BR PI0517348 A 20050926; CA 2580616 A 20050926; CN 200580032097 A 20050926; DE 102004047262 A 20040924; EP 05794600 A 20050926; JP 2007532767 A 20050926; MX 2007003488 A 20050926; RU 2007115380 A 20050926